Orange Book product · Brand (NDA)
FOSCAVIR
FOSCARNET SODIUM
At a glance
Sep 27, 1991
Approved
Brand (NDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 27, 1991
35 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
FOSCARNET SODIUM
Strength
6GM/250ML (24MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
NDA 020068
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2026FOSCARNET SODIUMGeneric (ANDA)
ANDA 220068 · CAPLIN
- 2024FOSCARNET SODIUMGeneric (ANDA)
ANDA 216602 · AMNEAL
- 2023FOSCARNET SODIUMGeneric (ANDA)
ANDA 213987 · SCIECURE
- 2023FOSCARNET SODIUMGeneric (ANDA)
ANDA 213807 · AVET LIFESCIENCES
- 2021FOSCARNET SODIUMGeneric (ANDA)
ANDA 213001 · GLAND
- 2021FOSCARNET SODIUMGeneric (ANDA)
ANDA 212483 · FRESENIUS KABI USA
- 2005FOSCARNET SODIUMGeneric (ANDA)
ANDA 077174 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

